Skip to main content
  • Notice of Privacy Incident
  • Medicaid Provider Termination Alert: Revalidation deadlines are approaching. Failure by providers to revalidate will lead to termination and payment suspension. Check your account now at https://impact.illinois.gov/ to learn if your required revalidation is due this month. More revalidation information here.
Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Meeting Results for: September 18, 2013

Drug Name Review Type Committee Recommendation Prior Approval Status � Final Determination
Abilify Maintena New Drug Initial Review Remove Prior Approval Requirement Prior Approval Required
Zubsolv New Drug Initial Review Require Prior Approval Prior Approval Required
Tivicay New Drug Initial Review Require Prior Approval Prior Approval Required
Linzess New Drug Initial Review Require Prior Approval Prior Approval Required
Tecfidera New Drug Appeal Require Prior Approval Prior Approval Required
Avonex PDL Appeal Remove Prior Approval Requirement Prior Approval Requirement Removed
Dulera PDL Appeal Remove Prior Approval Requirement Prior Approval Requirement Removed
Advair Diskus PDL Appeal Removed from Agenda Prior Approval Required